This presentation discusses the application of this morality exception from patentability presenting as examples Nanotechnology, Synthetic biology and Gene-editing. It will debate with particular incidence the topic of patentability of germ cells modification, and the interpretation of Article 6 (2) (b) of the Biotechnology Directive.
Period
2018 Sept 5 → 2018 Sept 8
Event title
37th ATRIP annual Congress: fairness, morality and ordre public in Intellectual Property (IP) law and policy